SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-19-002221
Filing Date
2019-08-19
Accepted
2019-08-19 16:39:12
Documents
4
Period of Report
2019-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1923416.htm 8-K 30325
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 236887
3 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 10313
4 image0.jpg GRAPHIC 83657
  Complete submission text file 0001178913-19-002221.txt   394018
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36621 | Film No.: 191036916
SIC: 2833 Medicinal Chemicals & Botanical Products